Gale SA, Acar D, Daffner KR. Dementia. Am J Med. 2018;131:1161–9.
Article
PubMed
Google Scholar
Dorszewska J, Prendecki M, Oczkowska A, Dezor M, Kozubski W. Molecular basis of familial and sporadic Alzheimer’s disease. Curr Alzheimer’s Res. 2016;13:952–63.
Article
CAS
Google Scholar
Vossel KA, Tartaglia MC, Nygaard HB, Zeman AZ, Miller BL. Epileptic activity in Alzheimer’s diseases: causes and clinical relevance. Lancet Neurol. 2017;16:311–22.
Article
PubMed
PubMed Central
Google Scholar
Canevelli M, Bruno G, Remiddi F, Vico C, Lacorte E, Vanacore N, Cesari M. Spontaneous reversion of clinical conditions measuring the risk profile of the individual: from frailty to mild cognitive impairment. Front. Med. (Lausanne) 2017;4:184. https://doi.org/10.3389/fmed.2017.00184.
World Health Organization. Global Action Plan on the Public Health Response to Dementia, 2017–2025. https:// apps.who.int/iris/bitstream/handle/10665/259615/978924151348 7-eng.pdf Accessed 31 May 2020.
Alzheimer’s Society. Dementia – the true cost: fixing the care crisis. https://www.alzheimers.org.uk/sites/default/files/2018-05/Dementia%20the%20true%20cost%20-%20Alzheimers%20Society%20report.pdf. Accessed 31 May 2020.
Cahill S, O’Shea E, Pierce M. Creating excellence in dementia care: a research review for Ireland’s National Dementia Strategy. 2012. www.icsg.ie, livingwithdementia.tcd.ie. Accessed 31 May 2020.
Pierce M, Cahill S, O’Shea E. Prevalence and projections of dementia in Ireland, 2011-2046, Genio, Mullingar. 2014.
Budson AE, Solomon PR. Cholinesterase inhibitors. Memory Loss, Alzheimer’s Disease, and Dementia, 160–173. Elsevier; 2016.
Cummings J, Passmore P, McGuinness B, Mok V, Chen C, Engelborghs S, et al. Souvenaid in the management of mild cognitive impairment: an expert consensus opinion. Alzheimers Res Ther. 2019;11:73. https://doi.org/10.1186/s13195-019-0528-6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cummings J, Lee G, Ritter A, Zhong K. Alzheimer’s disease drug development pipeline: 2018. Alzheimer’s Dement. (N.Y.) 2018;4:195–214.
Makin S. The amyloid hypothesis on trial. Nature. 2018;559:S4–7.
Article
CAS
PubMed
Google Scholar
Mehta D, Jackson R, Paul G, Shi J, Sabbagh M. Why do trials for Alzheimer’s disease drugs keep failing? A discontinued drug perspective for 2010-2015. Expert Opin Investig Drugs. 2017;26:735–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Du X, Wang X, Geng M. Alzheimer’s disease hypothesis and related therapies. Transl Neurodegener. 2018;7:2 https://doi.org/10.1186/s40035-018-0107-y.
Article
PubMed
PubMed Central
CAS
Google Scholar
Edwards FA. A unifying hypothesis for Alzheimer’s disease: from plaques to neurodegeneration. Trends Neurosci. 2019;42:310–22.
Article
CAS
PubMed
Google Scholar
World Health Organization, Neurological Disorders: Public Health Challenges. Geneva, World Health Organization, 2006. https://www.who.int/mental_health/neurology/neurodiso/en/. Accessed 31 May 2020.
Alzheimer’s Disease International. World Alzheimer report 2011: the benefits of early diagnosis and intervention. London: ADI; 2011. https://www.alz.co.uk/research/WorldAlzheimerReport2011.pdf.
Google Scholar
National Institute for Health and Care Excellence (UK). Dementia: assessment, management and support for people living with dementia and their carers. London: National Institute for Health and Care Excellence (UK); 2018.
The Dementia Care Pathway. Full implementation guidance. National Collaborating Centre for Mental Health. 2018; https://www.rcpsych.ac.uk/docs/default-source/improving-care/nccmh/dementia/nccmh-dementia-care-pathway-full-implementation-guidance.pdf?sfvrsn=cdef189d_6.
Kane JP, Richardson S, Allan L, Thomas A. Diagnosing dementia. Br J Hosp Med (Lond). 2016;77:C22–5.
Article
Google Scholar
Lang L, Clifford A, Wei L, Zhang D, Leung D, Augustine G, et al. Prevalence and determinants of undetected dementia in the community: a systematic literature review and a meta-analysis. BMJ Open. 2017;7:e011146. https://doi.org/10.1136/bmjopen-2016-011146.
Article
PubMed
PubMed Central
Google Scholar
Bradford A, Kunik ME, Schulz P, Williams SP, Hardeep S. Missed and delayed diagnosis of dementia in primary care: prevalence and contributing factors. Alzheimer Dis Assoc Disord. 2009;23:306–14.
Article
PubMed
PubMed Central
Google Scholar
Gaugler JE, Ascher-Svanum H, Roth DL, Fafowora T, Siderowf A, Beach TG. Characteristics of patients misdiagnosed with Alzheimer’s disease and their medication use: an analysis of the NACC-UDS database. BMC Geriatr. 2013;13:137. https://doi.org/10.1186/1471-2318-13-137.
Article
PubMed
PubMed Central
Google Scholar
Beach TG, Monsell SE, Phillips LE, Kukull W. Accuracy of clinical diagnosis of Alzheimer’s disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010. J Neuropathol Exp Neurol. 2012;71:266–73.
Article
PubMed
Google Scholar
Boise L, Camicioli R, Morgan DL, Rose JH, Congleton L. Diagnosing dementia: perspectives of primary care physicians. Gerontologist. 1999;39:457–64.
Article
CAS
PubMed
Google Scholar
Moore V, Cahill S. Diagnosis and disclosure of dementia – a comparative qualitative study of Irish and Swedish general practitioners. Aging Ment Health. 2013;17:77–84.
Article
PubMed
Google Scholar
Brodaty H, Woolf C, Andersen S, Barzilai N, Brayne C, Cheung KS-L, et al. ICC-dementia (International Centenarian Consortium - dementia): an international consortium to determine the prevalence and incidence of dementia in centenarians across diverse ethnoracial and sociocultural groups. BMC Neurol. 2016;16:52. https://doi.org/10.1186/s12883-016-0569-4.
Larner AJ. Impact of the National Dementia Strategy in a neurology-led memory clinic: 5-year data. Clin. Med. (Lond). 2014;14:216. https://doi.org/10.7861/clinmedicine.14-2-216.
Bell S, Harkness K, Dickson JM, Blackburn D. A diagnosis for £55: what is the cost of government initiatives in dementia case finding. Age Ageing. 2015;44:344–5.
Article
PubMed
Google Scholar
Liu D, Green E, Kasteridis P, Goddard M, Jacobs R, Wittenberg R, et al. Incentive schemes to increase dementia diagnoses in primary care in England: a retrospective cohort study of unintended consequences. Br J Gen Pract. 2019;69:e154–63. https://doi.org/10.3399/bjgp19X701513.
Article
PubMed
PubMed Central
Google Scholar
Hunter CA, Kirson NY, Desai U, Cummings AK, Faries DE, Birnbaum HG. Medical costs of Alzheimer’s disease misdiagnosis among US Medicare beneficiaries. Alzheimers Dement. 2015;11:887–95.
Article
PubMed
Google Scholar
Happich M, Kirson NY, Desai U, King S, Birbaum HG, Reed C, et al. Excess costs associated with possible misdiagnosis of Alzheimer’s disease among patients with vascular dementia in a UK CPRD population. J Alzheimers Dis. 2016;53:171–83.
Article
PubMed
PubMed Central
Google Scholar
Boise L, Morgan DL, Kaye J, Camicioli R. Delays in the diagnosis of dementia: perspectives of family caregivers. Am J Alzheimers Dis. 1999;14:20–6.
Article
Google Scholar
Minghella E. Pathways to dementia diagnosis: a review of services in the south-west of England. NHS South of England, Strategic Clinical Network for Mental Health, Dementia and Neurological Conditions South West. 2013. http://dementiapartnerships.com/wp-content/uploads/sites/2/pathwaystodiagnosis.pdf. Accessed 11th June, 2020.
Ewers M, Sperling RA, Klunk WE, Weiner MW, Hampel H. Neuroimaging markers for the prediction and early diagnosis of Alzheimer’s disease dementia. Trends Neurosci. 2011;34:430–42.
Article
CAS
PubMed
PubMed Central
Google Scholar
Quiroz YT, Zetterberg H, Reiman EM, Chen Y, Su Y, Fox-Fuller JT, et al. Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer’s disease kindred: a cross-sectional and longitudinal cohort study. Lancet Neurol. 2020;19:513–21.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vellas B, Bateman R, Blennow K, Frisoni G, Johnson K, Katz R, et al. Endpoints for pre-dementia AD trials: a report from the EU/US/CTAD Task Force. J Prev Alzheimers Dis. 2015;2:128–35.
CAS
PubMed
PubMed Central
Google Scholar
Schneider LS, Goldberg TE. Composite cognitive and functional measures for early stage Alzheimer’s disease trials. Alzheimers Dement. (Amst). 2020;12:e12017. https://doi.org/10.1002/dad2.12017.
Tong T, Thokala P, McMillan B, Ghosh R, Brazier J. Cost effectiveness of using cognitive screening tests for detecting dementia and mild cognitive impairment in primary care. Int J Geriatr Psychiatry. 2017;32:1392–400.
Article
PubMed
Google Scholar
Hornberger J, Bae J, Watson I, Johnston J, Happich M. Clinical and cost implications of amyloid beta detection with amyloid beta positron emission tomography imaging in early Alzheimer’s disease - the case of florbetapir. Curr Med Res Opin. 2017;33:675–85.
Article
CAS
PubMed
Google Scholar
Immon WH, Linstedt D. Data architecture: a primer for the data scientist: big data. Data Warehouse and Data Vault: Morgan Kaufmann; 2014.
Google Scholar
Milne R, Brayne C. We need to think about data governance for dementia research in a digital era. Alz Res Therapy. 2020;12:17 https://doi.org/10.1186/s13195-020-0584-y.
Article
Google Scholar
Koch T, Iliffe S. Implementing the National Dementia Strategy in England: evaluating innovative practices using a case study methodology. Dementia (Lond). 2011;10:487–98.
Article
Google Scholar
Pedersen AB, Mikkelsen EM, Cronin-Fenton D, Kristensen NR, Pham TM, Pedersen L, et al. Missing data and multiple imputation in clinical epidemiological research. Clin Epidemiol. 2017;9:157–66.
Article
PubMed
PubMed Central
Google Scholar
Chan K, Fowles JB, Weiner JP. Review: electronic health records and the reliability and validity of quality measures: a review of the literature. Med Care Res Rev. 2010;67:503–27.
Article
PubMed
Google Scholar
Kharrazi H, Wang C, Scharfstein D. Prospective EHR-based clinical trials: the challenge of missing data. J Gen Intern Med. 2014;29:976–8.
Article
PubMed
PubMed Central
Google Scholar
Bath P, Deeg D, Poppelaars J. The harmonisation of longitudinal data: a case study using data from cohort studies in The Netherlands and the United Kingdom. Ageing Soc. 2010;30:1419–37.
Article
Google Scholar
Little RJ, D’Agostino R, Cohen ML, Dickersin K, Emerson SS, Farrar JT, et al. The prevention and treatment of missing data in clinical trials. N Engl J Med. 2012;367:1355–60.
Article
CAS
PubMed
PubMed Central
Google Scholar
Miao X, Gao Y, Guo S, Liu W. Incomplete data management: a survey. Front Comput Sci. 2018;12:4–25.
Article
Google Scholar
Hu Z, Melton GB, Arsoniadis EG, Wang Y, Kwaan MR, Simon GJ. Strategies for handling missing clinical data for automated surgical site infection detection from the electronic health record. J Biomed Inform. 2017;68:112–20.
Article
PubMed
PubMed Central
Google Scholar
Kourou KD, Pezoulas VC, Georga EI, Exarchos TP, Tsanakas P, Tsinakis M, et al. Cohort harmonization and integrative analysis from a biomedical engineering perspective. IEEE Rev Biomed Eng. 2019;12:303–18.
Article
PubMed
Google Scholar
McCombe N, Ding X, Prasad G, Finn DP, Todd S, McClean PL, et al. Predicting feature imputability in the absence of ground truth. In: Proceedings of the 37th International Conference on Machine Learning (ICML): the Art of Learning with Missing Values (ARTEMISS) Workshop, Vienna, Austria, 17 July, 2020.
Clinical Record Initiative Search system (CRIS). https://crisnetwork.co/. Accessed 31 October 2020.
Hekler EB, Klasnja P, Chevance G, Golaszewski NM, Lewis D, Sim I. Why we need a small data paradigm. BMC Med. 2019;17:133 https://doi.org/10.1186/s12916-019-1366-x.
Article
PubMed
PubMed Central
Google Scholar
Alzheimer’s Society (2014): Dementia 2014: Opportunity for change. https://www.alzheimers.org.uk/sites/default/files/migrate/downloads/dementia_2014_opportunity_for_change.pdf.
LeCun Y, Bengio Y, Hinton G. Deep learning. Nature. 2015;521:436–44.
Article
CAS
PubMed
Google Scholar
Chen L, Hoey J, Nugent CD, Cook DJ, Yu Z. Sensor-based activity recognition. IEEE Trans. Syst. Man Cybern., Part C (Applications and Reviews). 2012;42:790–808.
Ienca M, Vayena E, Blasimme A. Big data and dementia: charting the route ahead for research, ethics, and policy. Front Med (Lausanne). 2018;5:13. https://doi.org/10.3389/fmed.2018.00013.
Wong-Lin K, Sanchez-Bornot JM, McCombe N, Kaur D, McClean PL, Zou X, et al. Computational neurology: computational modeling approaches in dementia. In: Wolkenhauer, Olaf (ed.). Systems medicine: integrative, qualitative and computational approaches, vol. 2, pp. 81-89. Oxford: Elsevier.
Dayan P, Abbott LF. Theoretical neuroscience. MIT Press. 2001.
Zou X, Coyle D, Wong-Lin K, Maguire L. Computational study of hippocampal-septal theta rhythm changes due to ß-amyloid-altered ionic channels. PLoS One. 2011;6:e21579.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zou X, Coyle D, Wong-Lin K, Maguire L. Beta-amyloid induced changes in A-type K+ current can alter hippocampo-septal network dynamics. J Comput Neurosci. 2012;32:465–77.
Article
PubMed
Google Scholar
Abuhassan K, Coyle D, Belatreche A, Maguire L. Compensating for synaptic loss in Alzheimer’s disease. J Comput Neurosci. 2014;36:19–37.
Article
PubMed
Google Scholar
Cutsuridis V, Moustafa AA. Multiscale models of pharmacological, immunological and neurostimulation treatments in Alzheimer’s disease. Drug Discov Today Dis Model. 2016;19:85–91 https://doi.org/10.1016/j.ddmod.2016.12.001.
Article
Google Scholar
Cutsuridis V, Moustafa, A. Computational models of Alzheimer’s disease Scholarpedia 2017;12: 32144. https://doi.org/10.4249/scholarpedia.32144.
Cutsuridis V, Moustafa, AA. Computational models of pharmacological and immunological treatment in Alzheimer’s disease, in: Computational models of brain and behavior. John Wiley & Sons, Ltd, Chichester, UK 2017:99–108. https://doi.org/10.1002/9781119159193.ch8.
Hassan M, Abbas Q, Seo SY, Shahzadi S, Al Ashwal H, Zaki N, et al. Computational modeling and biomarker studies of pharmacological treatment of Alzheimer’s disease (review). Mol Med Rep. 2018;18:639–55.
CAS
PubMed
PubMed Central
Google Scholar
Joshi A, Wang DH, Watterson S, McClean PL, Behera CK, Sharp T, et al. Opportunities for multiscale computational modelling of serotonergic drug effects in Alzheimer’s disease. Neuropharmacology. 2020;174:108118. https://doi.org/10.1016/j.neuropharm.2020.108118.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rystar R, Fornari E, Frackowiak RS, Ghika JA, Knyazeva MG. Inhibition in early Alzheimer’s disease: an fMRI-based study of effective connectivity. Neuroimage. 2011;57:1131–9.
Article
Google Scholar
Penny W, Iglesias-Fuster J, Quiroz YT, Lopera FJ, Bobes MA. Dynamic causal modeling of preclinical autosomal-dominant Alzheimer’s disease. J Alzheimers Dis. 2018;65:697–711.
Article
PubMed
PubMed Central
Google Scholar
Alderson TH, Bokde ALW, Kelso JAS, Maguire L, Coyle D. Metastable neural dynamics in Alzheimer’s disease are disrupted by lesions to the structural connectome. Neuroimage. 2018;183:438–55.
Article
PubMed
Google Scholar
Pearl J. Causality: models, reasoning and interference. 2nd Ed., Cambridge University Press. 2009.
Ding X, Bucholc M, Wang H, Glass DH, Wang H, Glass DH, et al. A hybrid computational approach for efficient Alzheimer’s disease classification based on heterogeneous data. Sci Rep. 2018;8:9774. https://doi.org/10.1038/s41598-018-27997-8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kelly CJ, Karthikesalingam A, Suleyman M, Corrado G, King D. Key challenges for delivering clinical impact with artificial intelligence. BMC Med. 2019;17:195 https://doi.org/10.1186/s12916-019-1426-2.
Article
PubMed
PubMed Central
CAS
Google Scholar
Car J, Sheikh A, Wicks P, Williams MS. Beyond the hype of big data and artificial intelligence: building foundations for knowledge and wisdom. BMC Med. 2019;17:143 https://doi.org/10.1186/s12916-019-1382-x.
Article
PubMed
PubMed Central
Google Scholar
Allen Brain Map. https://portal.brain-map.org/. Accessed 31 Oct 2020.
Collation of Connectivity Data for the Macaque (CoCoMac) database. http://cocomac.g-node.org/main/index.php. Accessed 31 Oct 2020.
Human Connectome Project (HCP). http://www.humanconnectomeproject.org/. Accessed 31 Oct 2020.
Cambridge Centre for Ageing Neuroscience (Cam-CAN) dataset inventory https://www.cam-can.org/. Accessed 31 Oct 2020.
Alzheimer’s Disease Neuroimaging Initiative (ADNI). http://adni.loni.usc.edu/. Accessed 31 Oct 2020.
National Alzheimer’s Coordinating Center (NACC). https://www.alz.washington.edu/. Accessed 31 Oct 2020.
UK Biobank. https://www.ukbiobank.ac.uk/. Accessed 31 Oct 2020.
Dementias Platform UK (DPUK). https://www.dementiasplatform.uk/. Accessed 31 Oct 2020.
European Medical Information Framework (EMIF). https://www.imi.europa.eu/projects-results/project-factsheets/emif. Accessed 31 Oct 2020.
European Prevention of Alzheimer’s Dementia Consortium (EPAD). http://ep-ad.org/. Accessed 31 Oct 2020.
AETIONOMY (Organising mechanistic knowledge about neurodegenerative diseases for the improvement of drug development and therapy). https://www.imi.europa.eu/projects-results/project-factsheets/aetionomy. Accessed 31 Oct 2020.
Neuronet (Efficiently Networking European Neurodegeneration Research). https://www.imi-neuronet.org/. Accessed 31 Oct 2020.
Bucholc M, Ding X, Wang H, Glass DH, Wang H, Prasad G, et al. A practical computerized decision support system for predicting the severity of Alzheimer’s disease of an individual. Expert Syst Appl. 2019;130:157–71.
Article
PubMed
PubMed Central
Google Scholar
Geerts H, Dacks PA, Devanarayan V, Haas M, Khachaturian ZS, Gordon MF, et al. Big data to smart data in Alzheimer’s disease: the brain health modeling initiative to foster actionable knowledge. Alzheimers Dement. 2016;12:1014–21.
Article
PubMed
Google Scholar
Alber M, Tepole AB, Cannon WR, De S, Dura-Bernal S, Garikipati K, et al. Integrating machine learning and multiscale modeling - perspectives, challenges, and opportunities in the biological, biomedical, and behavioral sciences. NPJ Digit Med. 2019;2:115. https://doi.org/10.1038/s41746-019-0193-y.
Article
PubMed
PubMed Central
Google Scholar
Qiu S, Joshi PS, Miller MI, Xue C, Zhou X, Karjadi C, et al. Development and validation of an interpretable deep learning framework for Alzheimer’s disease classification. Brain. 2020;awaa137. https://doi.org/10.1093/brain/awaa137.
Youssofzadeh V, McGuinness B, Maguire LP, Wong-Lin K. Multi-kernel learning with Dartel improves combined MRI-PET classification of Alzheimer’s disease in AIBL data: group and individual analyses. Front Hum Neurosci. 2017;11:380.
Article
PubMed
PubMed Central
CAS
Google Scholar
Hampel H, O’Bryant SE, Molinuevo JL, Zetterberg H, Masters CL, Lista S, et al. Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. Nat Rev Neurol. 2018;14:639–52.
Article
PubMed
PubMed Central
Google Scholar
Saeys Y, Inza I, Larrañaga P. A review of feature selection techniques in bioinformatics. Bioinformatics. 2007;23:2507–17.
Article
CAS
PubMed
Google Scholar
Leclercq M, Vittrant B, Martin-Magniette ML, Scott Boyer MP, Perin O, Bergeron A, et al. Large-scale automatic feature selection for biomarker discovery in high-dimensional OMICs data. Front Genet. 2019;10:452. https://doi.org/10.3389/fgene.2019.00452.
Article
CAS
PubMed
PubMed Central
Google Scholar
Koelewijn L, Lancaster TM, Linden D, Dima DC, Routley BC, Magazzini L, et al. Oscillatory hyperactivity and hyperconnectivity in young APOE-ɛ4 carriers and hypoconnectivity in Alzheimer’s disease. Elife. 2019;8:e36011. https://doi.org/10.7554/eLife.36011.
Article
PubMed
PubMed Central
Google Scholar
Yang S, Bornot JMS, Wong-Lin K, Prasad G. M/EEG-based bio-markers to predict the MCI and Alzheimer’s disease: a review from the ML perspective. IEEE Trans Biomed Eng. 2019;66:2924–35.
Article
PubMed
Google Scholar
Maestú F, Fernández A. Role of magnetoencephalography in the early stages of Alzheimer disease. Neuroimaging Clin N Am. 2020;30:217–27.
Article
PubMed
Google Scholar
Sanchez-Bornot JM, Lopez ME, Bruna R, Maestú F, Youssofzadeh V, Yang S, Finn DP, Todd S, McLean PL, Prasad G, Wong-Lin K. High-dimensional brain-wide functional connectivity mapping in magnetoencephalography. J Neurosci Methods. 2020;108991. https://doi.org/10.1016/j.jneumeth.2020.108991.
Sim I, Gorman P, Greenes RA, Haynes RB, Kaplan B, Lehmann H, et al. Clinical decision support systems for the practice of evidence-based medicine. J Am Med Inform Assoc. 2001;8:527–34.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hu C, Ju R, Shen Y, Zhou P, Li Q. Clinical decision support for Alzheimer’s disease based on deep learning and brain network. In: Proceedings of the IEEE International Conference on Communications (ICC), Kuala Lumpur, 2016, 2016:1–6, https://doi.org/10.1109/ICC.2016.7510831.
Bruun M, Frederiksen KS, Rhodius-Meester HFM, Baroni M, Gjerum, L, Koikkalainen J, et al. Impact of a clinical decision support tool on prediction of progression in early-stage dementia: a prospective validation study. Alzheimers Res. Ther. 2019;11:25 (2019). https://doi.org/10.1186/s13195-019-0482-3.
IMI RADAR-AD (Remote Assessment of Disease and Relapse – Alzheimer’s Disease) project. https://www.radar-ad.org/. Accessed 31 Oct 2020.
EDoN (Early Detection of Neurodegenerative diseases) project. https://edon-initiative.org/. Accessed 31 Oct 2020.
Newman C, Hodges J, Pearson S, Noad R. The design and implementation of a computer supported assessment of dementia-ACEmobile. Int J Integr Care. 2014;14. https://doi.org/10.5334/ijic.1784.
Gholipour B. Can you diagnose dementia from a gaming app? Scientific American; 2016.
Google Scholar
Carvalho CM, Christina D, Saade M, Conci A, Seixas FL, Laks J. A clinical decision support system for aiding diagnosis of Alzheimer’s disease and related disorders in mobile devices. In: Proceedings of the 2017 IEEE International Conference on Communications (ICC), Paris, 2017; 2017:1–6, https://doi.org/10.1109/ICC.2017.7996968.
Muniz-Terrera G, Watermeyer T, Danso S, Ritchie C. Mobile cognitive testing: opportunities for aging and neurodegeneration research in low- and middle-income countries. J Glob Health. 2019;9:020313.
Article
PubMed
PubMed Central
Google Scholar
Kourtis LC, Regele OB, Wright JM, Jones GB. Digital biomarkers for Alzheimer’s disease: the mobile/wearable devices opportunity. NPJ Digit Med. 2019;2:9 https://doi.org/10.1038/s41746-019-0084-2.
Article
PubMed
PubMed Central
Google Scholar
Kaur D, Bucholc M, Finn DP, Todd S, Wong-Lin K, McClean PL. Multi-time-point data preparation robustly reveals MCI and dementia risk factors. Alzheimers dementia (Amst);12(1):e12116. 2020. https://doi.org/10.1002/dad2.12116.
René JFM, Haaksma ML, Nuiz-Terrera G. Understanding and predicting the longitudinal course of dementia. Curr Opin Psychiatry. 2019;32:123–9.
Article
Google Scholar
Saunders S, Ritchie K, Russ T, Muniz-Terrera G. Ritchie C (2018). Evolution and future directions for the concept of mild cognitive impairment. Int. Psychogeriatr. 2018;30:1431–4.
Article
Google Scholar
Huys QJ, Maia TV, Frank MJ. Computational psychiatry as a bridge from neuroscience to clinical applications. Nat Neurosci. 2016;19:404–13.
Article
CAS
PubMed
PubMed Central
Google Scholar
Heinz A. An understanding of mental disorders: computational models for dimensional psychiatry. The MIT Press. 2017.
Khairat S, Marc D, Crosby W, Sanousi AAS. Reasons for physicians not adopting clinical decision support systems: critical analysis. JMIR Med Inform. 2018;6:e24. https://doi.org/10.2196/medinform.8912.
Article
PubMed
PubMed Central
Google Scholar